GLP-1RAs linked to lower subarachnoid haemorrhage risk in type 2 diabetes studies
Two retrospective studies in type 2 diabetes patients with unruptured intracranial aneurysms linked GLP-1RAs to lower non-traumatic subarachnoid haemorrhage risk. One study also showed lower all-cause mortality over five years.